Retatrutide, the triple-receptor agonist generating massive buzz in weight loss research, has people asking one question that has nothing to do with the scale
And there is more to come
(Lipohypertrophy) Injecting into the same location every week causes lipohypertrophy: thickened, fibrous subcutaneous fat from repeated tissue trauma
NO is an endogenously produced vasodilator and is largely implicated in hemostatic mechanisms [39] while, in tail amputation and heparin-/warfarin-administration models, both the NO-synthase (NOS)-blocker, L-NAME (thought to have a prothrombotic effect) [3] and NOS-substrate, L-arginine [presented with an antithrombotic effect) [3] were little investigated
Peterle L, Sanfilippo S, Borgia F, et al
Is this different from online GLP-1 clinics or med spas